 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Increased to C- at TheStreet
marketbeat.com - February 26 at 7:08 AM |
 | Analysts Anticipate ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Announce -$0.60 EPS
americanbankingnews.com - March 7 at 8:10 PM |
| ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 6.9%
americanbankingnews.com - March 5 at 7:33 PM |
| ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $65.00 by Analysts at Morgan Stanley
americanbankingnews.com - March 3 at 10:22 AM |
| ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 5.3%
americanbankingnews.com - March 2 at 7:02 PM |
| ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Raised to $63.00
americanbankingnews.com - March 2 at 10:02 AM |
| Equities Analysts Offer Predictions for ACADIA Pharmaceuticals Inc.'s Q1 2021 Earnings (NASDAQ:ACAD)
americanbankingnews.com - March 1 at 2:28 AM |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Expected to Post Q1 2021 Earnings of ($0.58) Per Share
americanbankingnews.com - March 1 at 2:28 AM |
 | ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
nasdaq.com - March 1 at 1:06 AM |
 | Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $65
benzinga.com - February 26 at 10:23 AM |
|
| ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 sales results.
benzinga.com - February 26 at 10:23 AM |
| ACADIA Pharmaceuticals' (ACAD) "Overweight" Rating Reaffirmed at Morgan Stanley
americanbankingnews.com - February 25 at 10:09 AM |
 | ACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 25 at 4:10 AM |
| ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives "Buy" Rating from Mizuho
americanbankingnews.com - February 25 at 1:02 AM |
| Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue Estimates
nasdaq.com - February 24 at 8:18 PM |
 | Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 8:18 PM |
| Recap: ACADIA Pharmaceuticals Q4 Earnings
finance.yahoo.com - February 24 at 8:18 PM |
 | Glaucoma Pharmaceuticals Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025
marketwatch.com - February 23 at 10:35 PM |
| A Preview Of ACADIA Pharmaceuticals's Earnings
benzinga.com - February 23 at 12:33 PM |
| Announcing: ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Increased An Energizing 191% In The Last Five Years
finance.yahoo.com - February 23 at 7:33 AM |
| Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
finance.yahoo.com - February 19 at 12:31 PM |
| Interesting ACAD Put And Call Options For April 1st
nasdaq.com - February 11 at 6:27 PM |
| Trade Alert: The CEO & Director Of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Stephen Davis, Has Sold Some Shares Recently
nasdaq.com - February 10 at 7:59 AM |
| Glaucoma Pharmaceuticals Market Analysis, Trends, Growth, Size, Share and Forecast 2019 to 2025
marketwatch.com - February 9 at 8:19 AM |
| Glaucoma Pharmaceuticals Market Size By Regional Industry Growth, Statistics And Forecast
marketwatch.com - February 1 at 1:42 PM |
| Acadia Pharmaceuticals Announces Commercial Leadership Change
finance.yahoo.com - January 27 at 6:07 PM |
| Interesting ACAD Put And Call Options For April 16th
nasdaq.com - January 6 at 1:40 PM |
| Interesting ACAD Put And Call Options For February 2021
nasdaq.com - December 18 at 1:18 PM |
| Mizuho Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target of $69
benzinga.com - December 17 at 7:35 PM |
| Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $60
benzinga.com - December 17 at 7:35 PM |
|
| Is ACAD A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 3:02 PM |
| Glaucoma Pharmaceuticals Market Research Analysis and Competitive Analysis 2020 to 2025 With Impact of Covid-19
marketwatch.com - December 9 at 7:28 AM |
| Why Is Acadia (ACAD) Up 9.7% Since Last Earnings Report?
finance.yahoo.com - December 4 at 4:29 PM |
| ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Shift From Loss To Profit
finance.yahoo.com - November 25 at 7:15 AM |
| Parkinson's Dyskinesia Market Size Report 2020 Global Industry Analysis by Trends, Revenue, Share, Revenue and Forecast to 2025
marketwatch.com - November 21 at 2:40 PM |
| Glaucoma Pharmaceuticals Market Analysis, Innovation Trends and Current Business Trends by 2025
marketwatch.com - November 20 at 6:39 PM |
| ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 2020 Stifel Virtual Healthcare Conference (Transcript)
seekingalpha.com - November 18 at 6:23 PM |
| Alzheimer’s Therapeutic Market 2020 Trends, Key Players, Manufacturers Data, Price Analysis, Company Profiling By Type, By Density Composition
marketwatch.com - November 10 at 3:52 AM |
| What's Behind Acadia Pharmaceuticals' Mixed Q3 Results
finance.yahoo.com - November 5 at 1:12 PM |
| ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 12:30 AM |
| Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 4 at 7:29 PM |
| Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 7:29 PM |
 | Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials
bloomberg.com - October 27 at 6:07 AM |
| Were Hedge Funds Wrong About Embracing ACADIA Pharmaceuticals Inc. (ACAD)?
finance.yahoo.com - October 26 at 10:34 PM |
 | Acadia Pharmaceuticals
fool.com - October 24 at 6:27 PM |
 | The Schizophrenia market is expected to increase with a CAGR of 6.89% for the study period 2017-2030 in the 7MM, estimates DelveInsight
prnewswire.com - October 21 at 2:05 PM |
 | The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin’s Wish”
businesswire.com - October 14 at 6:42 PM |
| Glaucoma Pharmaceuticals Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2026
marketwatch.com - September 15 at 12:30 PM |
| ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)
seekingalpha.com - September 14 at 8:38 PM |
| Acadia (ACAD) Down 12% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 4 at 2:42 PM |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 12:28 PM |
